Binayak Sinha

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Finerenone in type 2 diabetes and renal outcomes: A random-effects model meta-analysis
  2022 DOI: 10.21203/rs.3.rs-2113472/v1
  +Save
• Heterogeneity in cardiovascular deaths or hospitalizations for heart failure from cardiovascular outcome trials is linked to weight: A meta-regression analysis
  2022 DOI: 10.21203/rs.3.rs-2113284/v1
  +Save
• Using machine learning to assess cardiovascular risk in T2DM patients without established cardiovascular disease: The MARK-2 analysis
  2022 DOI: 10.21203/rs.3.rs-1569242/v1
  +Save
• The cardiovascular benefits of GLP1-RAs are related to their positive effect on glycemic control: A meta-regression analysis
  2022 DOI: 10.21203/rs.3.rs-1339432/v1
  +Save
• The cardiovascular benefits of GLP1-RA are directly related to their positive effect on glycaemic control: A meta-regression analysis
  2022 DOI: 10.37766/inplasy2022.1.0071
  +Save
• A meta-analysis of the effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on metabolic parameters in patients with polycystic ovary syndrome (PCOS)
  2021 DOI: 10.21203/rs.3.rs-806292/v1
  +Save
• A target HbA1c between 7 – 7.7% reduces macrovascular events in T2D regardless of duration of diabetes – a meta-analysis of randomized controlled trials
  2021 DOI: 10.1101/2021.03.11.21253387
  +Save
• Meta‐analysis of the effects of sodium glucose cotransporter 2 inhibitors in non‐alcoholic fatty liver disease patients with type 2 diabetes
  JGH Open 2021 DOI: 10.1002/jgh3.12473
  +Save
• Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome Trials
  Current Diabetes Reviews 2020 DOI: 10.2174/1573399816666200206113549
  +Save
• Is it Worth CANVASing for CREDENCE? A Benefit-risk Analysis
  Current Diabetes Reviews 2020 DOI: 10.2174/1573399815666191025094733
  +Save